hypusine has been researched along with deferiprone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrus, L; Grady, RW; Hanauske, AR; Hanauske-Abel, HM; Huima-Byron, T; Slowinska, B; Szabo, P; Zagulska, S | 1 |
| D'Alliessi Gandolfi, D; Hanauske-Abel, HM; Hoque, M; Mathews, MB; Palumbo, P; Park, MH; Pe'ery, T; Saxena, D | 1 |
2 other study(ies) available for hypusine and deferiprone
| Article | Year |
|---|---|
Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors: a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1).
Topics: Anti-HIV Agents; Apoptosis; Cell Line, Transformed; Deferiprone; Enzyme Inhibitors; Eukaryotic Translation Initiation Factor 5A; HIV Core Protein p24; HIV-1; Humans; Lysine; Microscopy, Electron; Mimosine; Mixed Function Oxygenases; Peptide Initiation Factors; Pyridones; RNA-Binding Proteins; RNA, Messenger; RNA, Viral; T-Lymphocytes; Virus Replication | 1998 |
Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.
Topics: Anti-HIV Agents; Ciclopirox; Deferiprone; Enzyme Inhibitors; Eukaryotic Translation Initiation Factor 5A; Gene Expression; HIV-1; Humans; Leukocytes, Mononuclear; Lysine; Mixed Function Oxygenases; Peptide Initiation Factors; Pyridones; RNA-Binding Proteins; Virus Replication | 2009 |